Alzheimer's Association will fund $1.5 mil. in biomedical research from Cognex royalty fund.

Executive Summary

ALZHEIMER's ASSN. TO FUND $1.5 MIL. OF RESEARCH VIA COGNEX ROYALTY FUND, according to the association's recent request for proposals. The RFP seeks biomedical research projects addressing the results of biological or pharmacological interventions for Alzheimer's disease. An earlier RFP offered $1.4 mil. in funding for psychosocial research projects. Funding for both programs will be provided through the "tacrine royalty fund," a royalty agreement based on the sales of Warner-Lambert's Cognex and administered by the Alzheimer's Association.